Back to Trades
Turtle Cameron
Chief Executive OfficerDirectorCIK 0001758363
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 12
- Buy transactions
- 0
- Sell transactions
- 25
- Companies
- 2
- Active
- 2025–2026
Turtle Cameron, Chief Executive Officer, Director, accounts for 12 disclosed filings worth $24.3M, spread across 2 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $7.3M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
12 loaded
| Jul 2 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $1.3M |
| Jun 3 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $1.1M |
| May 1 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $1.1M |
| Apr 3 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $739.9K |
| Mar 25 | DMRA Damora Therapeutics, Inc. | Turtle Cameron | Insider | Award | $860.1K |
| Mar 25 | DMRA Damora Therapeutics, Inc. | Turtle Cameron | Insider | Other | $0 |
| Mar 3 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $632.9K |
| Feb 4 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $492.0K |
| Jan 13 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Award | $16.2M |
| Jan 6 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $460.1K |
| Dec 3 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $435.4K |
| Nov 5 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $1.0M |
12 filings